# Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail

> **NCT01400594** · PHASE2 · COMPLETED · sponsor: **Hisamitsu Pharmaceutical Co., Inc.** · enrollment: 182 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** HTU-520 Patch
- **OTHER:** Placebo Patch

## Key facts

- **NCT ID:** NCT01400594
- **Lead sponsor:** Hisamitsu Pharmaceutical Co., Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 182 (ACTUAL)
- **Last updated:** 2015-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01400594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01400594, "Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01400594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*